biomedicina slovenica


pr=Barbič-Žagar : 37

  1. Soklič Tanja; Barbič-Žagar Breda; Debelak Tjaša
    Učinek kombiniranega pršila s ksilometazolinom in z dekspantenolom (Septanazal) na nosno kongestijo po operativnem posegu v nosu in obnosnih votlinah
    [Effect of xylometazoline and dexpanthenol combination nasal spray (Septanazal) on nasal congestion in patients after surgery in the nose and paranasal cavity]
    2021
  2. Požlep Gorazd; Barbič-Žagar Breda; Marinšek Gašper; Plut Špela
    Spremljanje učinkovitosti in varnosti zdravljenja pooperativne bolečine s kombinacijo tramadola in paracetamola
    [Study on the efficacy and safety of a tramadol and paracetamol combination in patients with postoperatiave pain]
    2020
  3. Jug Borut; Barbič-Žagar Breda; Grošelj Mateja; Milovanovič Jarh Darja; Lipušček Tjaša
    Neintervencijsko spremljanje učinkovitosti in varnosti zdravljenja z rosuvastatinom (Sorvasta) in uvajanje dodatnih jakosti v klinično prakso pri bolnikih s hiperlipidemijo - FROZEN
    [Non-interventional study of efficacy and safety of rosuvastatin (Sorvasta) therapy and introduction of additional strengths to clinical practice in patients with hyperlipidaemia - FROZEN]
    2019
  4. Barbič-Žagar Breda; Debelak Tjaša; Čežina Anastasija; Herman Ana
    Učinkovitost in varnost pastil z izvlečkom iz listov bršljana (35 mg) pri bolnikih z akutnim bronhitisom
    [Efficacy and safety of ivy leaf extract 35 mg lozenges in patients with cough in acute bronchitis]
    2020
  5. Petek Šter Marija; Barbič-Žagar Breda
    Treatment of patients with arterial hypertension in family medicine in Slovenia - Assessment of the situation after the introduction of modal practices
    [Obravnava bolnikov z arterijsko hipertenzijo v ambulantah družinske medicine v Sloveniji - Ocena stanja po uvedbi referenčnih ambulant]
    2021
  6. Čelofiga Andreja; Barbič-Žagar Breda; Vrzel Marina; Meško Obretan Jasna
    Učinkovitost in varnost duloksetina (Dulsevia) v odmerku po 90 mg v klinični praksi pri bolnikih z veliko depresivno motnjo ali generalizirano anksiozno motnjo
    [Efficacy and safety of duloxetine (Dulsevia) in the dose of 90 mg in patients with major depressive disorder or generalized anxiety disorder in clinical practice]
    2020
  7. Chazova Yevgenyevna Irina; Martynyuk Tetyana; Accetto Rok; Sirenko Yuriy; Vincelj Josip; Widimský Jiří; Barbič-Žagar Breda; Arhipov M. V.; Grinshtein Y. I.; Ostroumova O. D.
    The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor%) and its fixed combination with hydrochlorothiazide (Valsacor% H) in routine clinical practice in patients with grade 1 and grade 2 hypertension
    2017
  8. Chazova Yevgenyevna Irina; Martynyuk Tetyana; Accetto Rok; Sirenko Yuriy; Vincelj Josip; Widimský Jiří; Barbič-Žagar Breda; Arhipov M. V.; Grinshtein Y. I.; Ostroumova O. D.
    The influence of antyhypertensive therapy of valsartan and fixed combination with hydrochlorothiazide use on pulse-wave velocity and central arterial pressure in patients with arterial hypertension of 1-2 grades in international VICTORY clinical trial
    2018
  9. Accetto Rok; Chazova Yevgenyevna Irina; Sirenko Yuriy; Vincelj Josip; Widimský Jiří; Barbič-Žagar Breda
    The efficacy and safety of valsartan and combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension- the VICTORY trial
    2017
  10. Accetto Rok; Widimský Jiří; Vincelj Josip; Sirenko Yuriy; Chazova Yevgenyevna Irina; Barbič-Žagar Breda
    The efficacy and safety of valsartan and a combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension: a subgroup analysis of the effect of valsartan and its combination with ...
    2018
  11. Krevel Barbara; Barbič-Žagar Breda; Uranič Nataša
    Učinkovitost in varnost enega odmerka Flebavena (diosmin) po 1.000 mg dnevno pri bolnikih s kronično vensko boleznijo
    [The Efficacy and safety of a daily 1.000 mg dose of Flebaven (diosmin) in patients with chronic venous disease]
    2020
  12. Vasić Danijela; Novaković Marko; Božič Mojca; Barbič-Žagar Breda; Jug Borut
    Short-term water- and land-based exercise training comparably improve exercise capacity and vascular function in patients after a recent coronary event
    2019
  13. Barbič-Žagar Breda
    Z dokazi podprto zdravljenje s Krkinimi izdelki
    2014
  14. Blinc Aleš; Kozak Matija; Šabovič Mišo; Božič Mojca; Stegnar Mojca; Poredoš Pavel; Kravos Andrej; Barbič-Žagar Breda; Pohar Perme Maja; Stare Janez
    Preprečevanje ishemičnih dogodkov pri bolnikih s periferno arterijsko boleznijo
    2014
  15. Koprivšek Jure; Vrzel Marina; Barbič-Žagar Breda
    Učinkovitost in varnost aripiprazola v zdravljenju shizofrenije in bipolarne motnje
    [Efficacy and safety of aripiprazole in patients with shizophrenia and bipolar mania]
    2017
  16. Blinc Aleš; Kozak Matija; Šabovič Mišo; Božič Mojca; Stegnar Mojca; Poredoš Pavel; Kravos Andrej; Barbič-Žagar Breda; Stare Janez; Pohar Perme Maja
    Survival and event-free survival of patients with peripheral arterial disease undergoing prevention of cardiovascular disease
    2017
  17. Rotar-Pavlič Danica; Kitak Teja; Barbič-Žagar Breda
    Neintervencijsko spremljanje učinkovitosti in varnosti fiksne kombinacije perindoprila in amlodipina (Amlessa) v zdravljenju arterijske hipertenzije in vpliva dodatnih dejavnikov tveganja za srčno-žilne bolezni na bolnikovo zavzetost za zdravljenje (COMIPLANT)
    [Post-authorization efficacy and safety study of treatment with fixed-dose combination of perindopril and amlodipine (Amlessa) in patients with arterial hypertension and the impact of additional risk factors for cardiovascular diseases on patient compliance (COMPLIANT)]
    2016
  18. Blinc Aleš; Kozak Matija; Šabovič Mišo; Božič Mojca; Stegnar Mojca; Poredoš Pavel; Kravos Alenka; Barbič-Žagar Breda; Pohar Perme Maja; Stare Janez
    What to expect from prevention cardiovascular disease in patients with peripheral arterial disease
    2015
  19. Blinc Aleš; Kozak Matija; Šabovič Mišo; Božič Mojca; Stegnar Mojca; Poredoš Pavel; Kravos Alenka; Barbič-Žagar Breda; Pohar Perme Maja; Stare Jernej
    Cardiovascular disease prevention in paients with peripheral arterial disease-results of a 5-year observational study
    2014
  20. Blinc A; Kozak M; Šabovič M; Božič M; Stegnar M; Poredoš P; Kravos A; Barbič-Žagar B; Pohar-Perme M; Stare J
    Prevention of ischemic events in patients with peripheral arterial disease design, baseline characteristics and 2-year results an observational study
    2011
  21. Blinc Aleš; Kozak Matija; Šabovič Mišo; Božič Mojca; Stegnar Mojca; Poredoš Pavel; Kravos Andrej; Barbič-Žagar Breda; Pohar-Perme Maja; Stare Janez
    Is it possible to prevent CV events in PAD patients? (Results of PID-PAB study)
    2011
  22. Bon Jurij; Barbič-Žagar Breda; Bevec Matevž
    Neintervencijsko spremljanje učinkovitosti in varnosti olanzapina (Zolrix) v zdravljenju shizofrenije in bipolarne manije
    [Post-authorization safety and efficacy study of olanzapine (Zolrix) in the treatment of shizophrenia and bipolar mania]
    2011
  23. Blinc A; Kozak M; Šabovič M; Božič M; Stegnar M; Poredoš P; Kravos A; Barbič-Žagar B; Pohar-Perme M; Stare J
    Prevention of ischaemic events in patients with peripheral arterial disease according to the European guidelines on cardiovascular disease prevention in practice
    2009
  24. Bedenčič M; Blinc A; Božič M; Stegnar M; Kozak M; Šabovič M; Poredoš P; Kravos A; Barbič-Žagar B; Pohar-Perme M; Stare J
    Association of haemostatic and inflammatory markers with future ischemic cardiovascular events in patients with peripheral arterial disease - initial laboratory results of the prevention of ischemic events in patients with peripheral arterial disease (PID)
    2009
  25. Blinc Aleš; Kozak Matija; Šabovič Mišo; Božič Mojca; Stegnar Mojca; Poredoš Pavel; Kravos Andrej; Barbič-Žagar Breda; Pohar-Perme Maja; Stare Janez
    Slovenska raziskava o preprečevanju ishemičnih zapletov pri bolnikih s periferno arterijsko boleznijo - 2-letni rezultati raziskave PIB-PAB
    2009
  26. Barbič-Žagar Breda; Ristovski Aleksandar; Dular-Meglič Tina
    Ocena učinkovitosti, varnosti in sprejemljkivosti orodisperzibilnega risperidona pri bolnikih s shizofrenijo ali bipolarno manijo in pri vedenjskih motnjah dementnih bolnikov
    [Evaluation of efficacy, safety and acceptability of orodispersible risperidone in patients with schizophrenia, bipolar mania and behavioural disturbances in dementia patients]
    2008
  27. Barbič-Žagar Breda; Kos Jernej; Grošelj Mateja
    Klinične izkušnje z atorvastatinom v visokih odmerkih
    [Clinical experience with high doses of atorvastatin]
    2007
  28. Blinc Aleš; Kozak Matija; Šabovič Mišo; Poredoš Pavel; Kravos Andrej; Barbič-Žagar Breda; Stare Janez; Pohar-Perme Maja
    Preprečevanje ishemičnih dogodkov pri bolnikih s periferno arterijsko boleznijo - raziskava PID-PAB: načrt raziskave, značilnosti preiskovancev ob vključitvi in delni rezultati po enem letu
    2008
  29. Barbič-Žagar Breda
    Učinkovitost in varnost Vasilipa pri bolnikih s hiperholesterolemijo
    [The efficacy and safety of Vasilip in patients with hypercholesterolemia]
    2002
  30. Barbič-Žagar Breda; Drinovec Jože
    Predgovor
    2002
  31. Mrhar Aleš; Barbič-Žagar Breda
    Farmakoekonomski pogledi na zdravljenje s statini
    2000
  32. Barbič-Žagar Breda
    Medikamentno zdravljenje srčnega popuščanja
    1999
  33. Barbič-Žagar B; Oblak D
    Vloga zdravil pri preprečevanju bolezni srca in ožilja
    1998
  34. Barbič-Žagar Breda
    Pomen antihipertenzivnega zdravljenja s fiksnimi kombinacijami zdravil
    1997
  35. Barbič-Žagar Breda
    Nekateri farmakoekonomski pogledi na zdravljenje srčnega popuščanja
    1997
  36. Barbič-Žagar Breda
    Farmakoekonomski vidiki hipolipemičnih zdravil
    [Pharmacoeconomic aspects of hypolipemic drugs]
    1998
  37. Barbič-Žagar Breda
    Mesto pentoksifilina pri kritični ishemiji udov
    1997


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics